Literature DB >> 34148215

Molecular Mechanism of Neuroprotective Effect of Melatonin on Morphine Addiction and Analgesic Tolerance: an Update.

Ling-Yan Su1,2,3, Qianjin Liu4,5,6, Lijin Jiao4,5,6, Yong-Gang Yao7,8,9,10.   

Abstract

Drug addiction is a global health problem and continues to place an enormous financial burden on society. This addiction is characterized by drug dependence sensitization and craving. Morphine has been widely used for pain relief, but chronic administration of morphine causes analgesic tolerance, hyperalgesia, and addiction, all of which limit its clinical usage. Alterations of multiple molecular pathways have been reported to be involved in the development of drug addiction, including mitochondrial dysfunction, excessive oxidative stress and nitric oxide stress, and increased levels of apoptosis, autophagy, and neuroinflammation. Preclinical and clinical studies have shown that the co-administration of melatonin with morphine leads to a reversal of these affected pathways. In addition, murine models have shown that melatonin improves morphine-induced analgesic tolerance and addictive behaviors, such as behavioral sensitization, reward effect, and physical dependence. In this review, we attempt to summarize the recent findings about the beneficial effect and molecular mechanism of melatonin on mitochondrial dysfunction, uncontrolled autophagy, and neuroinflammation in morphine addiction and morphine analgesic tolerance. We propose that melatonin might be a useful supplement in the treatment opiate abuse.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Analgesic tolerance; Autophagy; Melatonin; Mitochondrial dysfunction; Morphine addiction; Neuroinflammation

Mesh:

Substances:

Year:  2021        PMID: 34148215     DOI: 10.1007/s12035-021-02448-0

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  97 in total

Review 1.  The neuropsychological basis of addictive behaviour.

Authors:  B J Everitt; A Dickinson; T W Robbins
Journal:  Brain Res Brain Res Rev       Date:  2001-10

Review 2.  Addiction and the brain: the neurobiology of compulsion and its persistence.

Authors:  S E Hyman; R C Malenka
Journal:  Nat Rev Neurosci       Date:  2001-10       Impact factor: 34.870

Review 3.  Pharmacotherapy of addictions.

Authors:  Mary Jeanne Kreek; K Steven LaForge; Eduardo Butelman
Journal:  Nat Rev Drug Discov       Date:  2002-09       Impact factor: 84.694

4.  Addiction is a brain disease, and it matters.

Authors:  A I Leshner
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

5.  Decreased mitochondrial DNA copy number in the hippocampus and peripheral blood during opiate addiction is mediated by autophagy and can be salvaged by melatonin.

Authors:  Yue-Mei Feng; Yun-Fang Jia; Ling-Yan Su; Dong Wang; Li Lv; Lin Xu; Yong-Gang Yao
Journal:  Autophagy       Date:  2013-06-20       Impact factor: 16.016

Review 6.  Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies.

Authors:  Nora D Volkow; A Thomas McLellan
Journal:  N Engl J Med       Date:  2016-03-31       Impact factor: 91.245

7.  Melatonin enhances the rewarding properties of morphine: involvement of the nitric oxidergic pathway.

Authors:  Noushin Yahyavi-Firouz-Abadi; Pouya Tahsili-Fahadan; Mohammad Hossein Ghahremani; Ahmad Reza Dehpour
Journal:  J Pineal Res       Date:  2007-04       Impact factor: 13.007

8.  Atg5- and Atg7-dependent autophagy in dopaminergic neurons regulates cellular and behavioral responses to morphine.

Authors:  Ling-Yan Su; Rongcan Luo; Qianjin Liu; Jing-Ran Su; Lu-Xiu Yang; Yu-Qiang Ding; Lin Xu; Yong-Gang Yao
Journal:  Autophagy       Date:  2017-07-19       Impact factor: 16.016

Review 9.  Neurocircuitry of addiction.

Authors:  George F Koob; Nora D Volkow
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

10.  Melatonin alleviates morphine analgesic tolerance in mice by decreasing NLRP3 inflammasome activation.

Authors:  Qianjin Liu; Ling-Yan Su; Chunli Sun; Lijin Jiao; Ying Miao; Min Xu; Rongcan Luo; Xin Zuo; Rongbin Zhou; Ping Zheng; Wei Xiong; Tian Xue; Yong-Gang Yao
Journal:  Redox Biol       Date:  2020-04-29       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.